Skip to main content

Table 2 Treatment uptake as defined by percentage of hepatitis C antibody-positive study participants who received treatment

From: A systematic review of Hepatitis C virus treatment uptake among people who inject drugs in the European Region

Author, year % treated (# treated/# of treatment candidates) SVR (%) (# with sustained viral response/# treated)
Cournot et al, 2004 36% (81/225) Intent-to-treat: 26% (26/99)1
Crespo et al, 2001 64% (268/416) NA
Cullen et al, 2007 3% (3/104) NA
Defossez et al, 2008 16% (13/84)2 NA
Grando-Lemaire et al, 2002 12% (27/225) Intent-to-treat: 19% (5/27)
As-treated: 33% (5/15)
Jack et al, 2009 17% (30/174) Intent-to-treat: 62% (13/21)
As-treated: 77% (13/17)
Jowett et al, 2000 20% (50/253) Intent-to-treat: 36% (18/50)
Kristensen et al, 2009 4% (6/160) NA
Lindenburg et al, 2011 21% (58/277) Intent-to-treat: 65% (37/57)
As-treated: 77% (37/48)
Schulte et al, 2010 9% (26/301) Intent-to-treat: 69% (18/26)
As-treated: 86% (18/21)
  1. 1. Calculated according to the number of treatment outcomes (N=99) rather than the number of patients (N=81)
  2. 2. Study population represents study cohorts from a cross-sectional survey carried out at three time points: 1997 (N=35), 2000 (N=19) and 2003 (N=30).
\